期刊
CURRENT OPINION IN PHARMACOLOGY
卷 60, 期 -, 页码 331-340出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2021.08.009
关键词
-
资金
- Research Fund of the University of Basel for Excellent Junior Researchers
- Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration
This review provides a comprehensive summary of the most promising neuroprotective and neuroregenerative therapies under investigation, with a particular focus on neuroregenerative treatments such as neuropharmacological and cell-based approaches. Exciting investigational areas of biomaterial scaffolds and neuromodulation therapies are also highlighted.
Traumatic spinal cord injuries (SCIs) have far-reaching physical, social, and financial consequences. While medical advancements have improved supportive therapeutic measures for SCI patients, no effective neuroregenerative therapeutic options exist to date. Instead, the paradigm of SCI therapy is inevitably directed towards damage control rather than the restoration of a state of functional independence. Facing a continuous increase in the prevalence of spinal cord injured patients, neuroprotective and neuroregenerative strategies have earned tremendous scientific interest. This review intends to provide a robust summary of the most promising neuroprotective and neuroregenerative therapies currently under investigation. While we highlight encouraging neuroprotective strategies as well, the focus of this review lies on neuroregenerative therapies, including neuropharmacological and cell-based approaches. We finally point to the exciting investigational areas of biomaterial scaffolds and neuromodulation therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据